about
Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancerRecommendations for myeloid-derived suppressor cell nomenclature and characterization standardsImpact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyStimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming.Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusionMonocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell linesAHNAK and inflammatory markers predict poor survival in laryngeal carcinomaGenetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes.Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes.EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma.Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.Anti-epidermal growth factor receptor (EGFR) antibodies overcome resistance of ovarian cancer cells to targeted therapy and natural cytotoxicityTumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function.Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human.pJC20 and pJC40--two high-copy-number vectors for T7 RNA polymerase-dependent expression of recombinant genes in Escherichia coli.A member of the ClpB family of stress proteins is expressed during heat shock in Leishmania spp.Leishmania donovani heat shock protein 100. Characterization and function in amastigote stage differentiation.Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice--role of toll-like-receptor 4 expressed on host cells.Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.Vaccination Against Human Papilloma Viruses Leads to a Favorable Cytokine Profile of Specific T Cells.Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion.Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody-mediated depletion of Ly-6G+ cells in tumor-bearing mice.Capsular arabinomannans from Mycobacterium avium with morphotype-specific structural differences but identical biological activity.Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.CD11c.DTR mice develop a fatal fulminant myocarditis after local or systemic treatment with diphtheria toxin.
P50
Q24799512-B37E1EB3-62E0-41FA-BF29-CF7B2B2784CFQ26744395-1520143A-1AA8-476E-944A-0B61F39960CEQ27852901-1B180258-4F8D-40B6-AC86-78BDB179B7EDQ33576188-0A36D345-AA73-464E-8C0C-3932BA1BCDA6Q34219544-8D3BA580-4EB9-4178-97A1-67D7D46B8C79Q34433649-3D95F4A1-0FF5-4997-A137-D7D11AE25AB1Q34586928-AF8DA97D-953D-4B4E-8409-B7F1678342C2Q34721438-870AB761-18F0-4247-AED6-7185AC011CAFQ35197371-0C3D44F0-4731-4198-872C-E44414E8346AQ35264761-0BAB82F8-F160-43F4-9C7E-132B90832A5EQ35416013-8E1E0A73-6378-4E02-84EE-35E6CA616E5AQ35737437-48BA226D-B812-4A88-A0B3-01C9DC6E4F6AQ36321894-7F0414BB-BB5C-4A09-8033-72532B3BED0AQ36602010-FFA2EE47-0BAD-4BA5-9F05-0E2583667E12Q36866916-8EF58D57-BA69-40CE-8699-A1FCEE994EA8Q37077035-8ADA3ADB-C2A6-425E-AEC1-C2769307D977Q37681801-F70FB185-3FED-4E8B-8141-63FB9982B922Q38086392-780E8FF4-79DE-4AEC-B88E-C618439F243DQ38638345-9705A454-3D26-4E30-8D28-BB6480BCE035Q38781955-C655A5C4-18A8-4471-BC7C-A4E206F31AF4Q38805069-F158E4A6-9764-4395-88BB-9D222EB6DB32Q38815765-AE8A304F-7059-4348-828B-4EA7FD06F2F4Q38949020-E6515961-DA3A-42ED-A8DC-CF7B083AA794Q39091326-0AAD9C59-B96A-4A00-B9AE-919B3F75B439Q39148754-61290D27-A62B-4A77-B060-DB6ECC6C5F4BQ39436293-08E7B716-61E6-40ED-8134-723B8E60DF97Q39462264-7799141F-4C58-4F99-9344-42756D844777Q39467198-46B24DDE-0E27-48EA-88E4-D9C870FC0A75Q39476748-E1C84862-CF5A-4B7E-8AA7-6EA4B58593E9Q39596916-981F81FD-B8FA-4EBF-ABD1-5E8577465173Q39614791-87E2AE7D-7B0B-4DA7-90F1-A85A3EC5A272Q39633941-0AEDE315-2A6C-4110-9834-703BDFEB253CQ39753209-3F111781-3D10-4243-845D-0C6D5C2E25D3Q39885205-A0DB1CDE-4F36-42D6-9876-87474410DD19Q40050762-AF1DE055-27E5-4662-BA31-F2B2F97C207BQ40140978-26007DBB-EDB9-47AB-B6D8-C13F0581777CQ40148008-E8C22A5C-12F4-4995-9308-7820B10865AAQ40515074-710FE4D1-0354-4C73-B272-B84DB158C602Q40591069-EE05E0F9-D98C-443B-8006-626CF70A3B9CQ40672952-4CC33F5D-FE3C-4905-986D-AF5BF8EEC6BB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sven Brandau
@ast
Sven Brandau
@en
Sven Brandau
@es
Sven Brandau
@nl
Sven Brandau
@sl
type
label
Sven Brandau
@ast
Sven Brandau
@en
Sven Brandau
@es
Sven Brandau
@nl
Sven Brandau
@sl
prefLabel
Sven Brandau
@ast
Sven Brandau
@en
Sven Brandau
@es
Sven Brandau
@nl
Sven Brandau
@sl
P106
P1153
7003624762
P21
P31
P496
0000-0002-2702-4163